All Practice Exams

101+ Free Albania Pharmacist State Exam (Provimi i Shtetit - Farmaci) Practice Questions

Prepare for the Provimi i Shtetit për Profesionin e Rregulluar të Farmacistit (Albanian Pharmacist State Licensing Examination) exam with instant access — no signup required.

✓ No registration✓ No credit card✓ No hidden fees✓ Start practicing immediately
101+ Questions
100% Free

Loading practice questions...

2026 Statistics

Key Facts: Albania Pharmacist State Exam (Provimi i Shtetit - Farmaci) Exam

Law No. 10171 & Law No. 105/2014

Governing Law

Kuvendi i Shqipërisë - Law on Regulated Professions & Law on Drugs

QSHA & UFSH

Administering Body

Qendra e Shërbimeve Arsimore (Educational Services Center)

Not published (60 min)

Official Exam Length

QSHA Rregullore, Urdher nr. 365, date 28.12.2020

50% of points (grade 5)

Pass Threshold

QSHA - Informacion Lidhur me Provimin e Shtetit ne Profesionet e Rregulluara

10,000 ALL

First-Attempt Fee

Ministry of Education and Sports Tariffs

QSHA Center, Tirana

Testing Location

QSHA Official Testing Center Facility

UFSH Registration

Licensing Authority

Urdhri i Farmacistëve të Shqipërisë (UFSH)

Mandatory national licensing exam for Albanian pharmacy graduates, delivered by computer at QSHA in Tirana in one 60-minute round and passed with at least 50% of the paper's points, after which the graduate registers with UFSH. Before applying, candidates must complete the supervised professional practice and pass UFSH's practical skills assessment (Provimi i Vlerësimit të Aftësimit Praktik, VAP). This English-language prep bank offers 101 practice questions across the five disciplines of the official orientation programme; it is a study adaptation, not an official translation or a format simulation.

Sample Albania Pharmacist State Exam (Provimi i Shtetit - Farmaci) Practice Questions

Try these sample questions to test your Albania Pharmacist State Exam (Provimi i Shtetit - Farmaci) exam readiness. Each question includes a detailed explanation. Start the interactive quiz above for the full 101+ question experience with AI tutoring.

1Which molecular mechanism explains the antihypertensive and cardioprotective efficacy of Angiotensin-Converting Enzyme (ACE) inhibitors such as ramipril and enalapril?
A.Direct blockade of vascular smooth muscle L-type voltage-gated calcium channels
B.Inhibition of the zinc-metallopeptidase enzyme converting angiotensin I to angiotensin II and prevention of bradykinin degradation
C.Competitive antagonism at the angiotensin II type 1 (AT1) G-protein coupled receptor
D.Selective blockade of beta-1 adrenergic receptors in cardiac myocytes and juxtaglomerular cells
Explanation: ACE inhibitors competitively inhibit angiotensin-converting enzyme (a zinc metallopeptidase), blocking the conversion of inactive angiotensin I into potent vasoconstrictor angiotensin II. This reduces systemic vascular resistance, lowers aldosterone secretion, and diminishes sympathetic activity. Additionally, because ACE is identical to kininase II, inhibiting it prevents bradykinin breakdown, promoting nitric oxide-mediated vasodilation and cardiac remodeling protection, while also explaining the characteristic dry cough.
2What is the primary cellular target of beta-lactam antibiotics (e.g., amoxicillin, cephalosporins) responsible for their bactericidal activity against proliferating bacteria?
A.Penicillin-binding proteins (transpeptidases) responsible for cross-linking bacterial peptidoglycan cell wall chains
B.The 30S ribosomal subunit inhibiting aminoacyl-tRNA binding during protein translation
C.Bacterial DNA topoisomerase II (DNA gyrase) preventing DNA supercoiling during replication
D.Dihydropteroate synthase preventing bacterial folic acid synthesis from para-aminobenzoic acid
Explanation: Beta-lactam antibiotics mimic the D-Ala-D-Ala terminus of peptidoglycan precursor chains and covalently bind to the active serine site of Penicillin-Binding Proteins (PBPs / transpeptidases). This irreversible transpeptidation inhibition halts peptidoglycan cross-linking in growing bacterial cell walls. Subsequent activation of endogenous bacterial autolysins leads to osmotic lysis and cell death.
3A 54-year-old patient is newly diagnosed with Type 2 Diabetes Mellitus. Which mechanism accounts for the primary therapeutic glucose-lowering effect of first-line agent Metformin?
A.Closure of ATP-sensitive K+ channels in pancreatic beta-islet cells stimulating exocytosis of insulin
B.Inhibition of sodium-glucose cotransporter-2 (SGLT2) in the proximal renal tubules to enhance glucosuria
C.Activation of AMP-activated protein kinase (AMPK) leading to suppressed hepatic gluconeogenesis and increased peripheral insulin sensitivity
D.Reversible competitive inhibition of intestinal brush-border alpha-glucosidase enzymes delaying carbohydrate breakdown
Explanation: Metformin is a biguanide that accumulates in hepatocytes and selectively inhibits mitochondrial respiratory chain complex I. This increases the intracellular AMP/ATP ratio, thereby activating AMP-activated protein kinase (AMPK). Activated AMPK downregulates key gluconeogenic enzymes (PEPCK and glucose-6-phosphatase), reducing hepatic glucose output by over 60% and modestly improving peripheral insulin-mediated glucose uptake without causing hypoglycemia.
4Which electrophysiological and receptor-level action best describes how benzodiazepines such as diazepam and lorazepam produce anxiolytic and sedative effects?
A.Direct opening of central voltage-gated potassium channels leading to sustained membrane repolarization
B.Competitive blockade of post-synaptic serotonin 5-HT2A receptors in the cerebral cortex
C.Inhibition of the presynaptic reuptake of gamma-aminobutyric acid via GAT-1 transporters
D.Positive allosteric modulation of GABA-A receptors increasing the opening frequency of ligand-gated chloride channels
Explanation: Benzodiazepines bind allosterically to a specific interface between alpha and gamma subunits on ionotropic GABA-A receptors. This binding enhances the affinity of GABA for its primary binding site, increasing the opening frequency of the central chloride ion pore. The resulting influx of chloride ions hyperpolarizes the neuronal membrane, diminishing neuronal excitability and eliciting sedation, anxiolysis, muscle relaxation, and anticonvulsant activity.
5What is the primary mechanism of action by which 3-hydroxy-3-methylglutaryl-coenzyme A (HMG-CoA) reductase inhibitors (statins) lower circulating plasma LDL cholesterol levels?
A.Reversible competitive inhibition of HMG-CoA reductase, upregulating hepatic LDL receptor expression and clearing circulating ApoB-containing particles
B.Selective inhibition of the Niemann-Pick C1-Like 1 (NPC1L1) cholesterol transport protein in the jejunal brush border
C.Sequestration of bile acids in the intestinal lumen preventing enterohepatic recirculation
D.Direct degradation of apolipoprotein B-100 through antisense oligonucleotide binding
Explanation: Statins structurally mimic the HMG-CoA intermediate, competitively inhibiting HMG-CoA reductase—the rate-limiting enzyme in de novo hepatic cholesterol biosynthesis. The resulting depletion of intracellular hepatic cholesterol triggers sterol regulatory element-binding protein 2 (SREBP-2) cleavage, which upregulates cell-surface LDL receptor expression. This dramatically enhances clearance of circulating LDL and VLDL remnant particles from plasma.
6Which intracellular signaling pathway is stimulated by short-acting beta-2 adrenergic agonists (SABAs) like salbutamol to achieve rapid bronchodilation during an acute asthma exacerbation?
A.Coupling to Gq proteins leading to phospholipase C activation and intracellular calcium release
B.Coupling to Gs proteins, activating adenylyl cyclase to increase cyclic AMP (cAMP) and activate Protein Kinase A (PKA)
C.Direct inhibition of cyclic nucleotide phosphodiesterase-4 (PDE4) enzymes within bronchial smooth muscle
D.Antagonism of cysteinyl leukotriene CysLT1 receptors on mast cells and eosinophils
Explanation: Salbutamol selectively binds to Gs-protein-coupled beta-2 adrenergic receptors on airway smooth muscle cells. This activates adenylyl cyclase, converting ATP into intracellular cyclic adenosine monophosphate (cAMP). Elevated cAMP activates Protein Kinase A (PKA), which phosphorylates myosin light chain kinase (inactivating it) and promotes intracellular calcium extrusion, resulting in rapid bronchial smooth muscle relaxation.
7Omeprazole and other proton pump inhibitors (PPIs) require specific physiological activation to suppress gastric acid production. Where and how does this activation occur?
A.In the hepatic endoplasmic reticulum through cytochrome P450 2C19 oxidation before reaching the stomach
B.In the duodenal lumen where alkaline pancreatic secretions convert the prodrug into an active base
C.In the acidic canaliculi of gastric parietal cells where protonation yields a reactive tetracyclic sulfenamide that forms covalent disulfide bonds with H+/K+-ATPase
D.In systemic circulation via plasma esterases cleaving an inactive ester pro-moiety
Explanation: PPIs are weak lipophilic bases (pKa ~4.0) administered as enteric-coated formulations to bypass gastric acidity. Once absorbed systemically, they concentrate selectively in the highly acidic secretory canaliculi of active parietal cells (pH < 1.0). Protonation traps them and rearranges them into active sulfenamide intermediates, which covalently bind accessible cysteine residues (especially Cys813) on the luminal alpha subunit of the H+/K+-ATPase proton pump, permanently disabling acid secretion.
8In emergency pharmacotherapy for symptomatic sinus bradycardia, what is the precise pharmacological action of intravenous atropine sulfate?
A.Direct stimulation of cardiac beta-1 adrenoceptors to accelerate sinoatrial node automaticity
B.Inhibition of cardiac sodium-potassium ATPase pumps to induce positive inotropy
C.Blockade of funny (If) hyperpolarization-activated cyclic nucleotide-gated channels in nodal tissue
D.Competitive muscarinic M2 receptor antagonism abolishing vagal parasympathetic tone at the sinoatrial and atrioventricular nodes
Explanation: Atropine is a competitive antimuscarinic agent that reversibly occupies cardiac muscarinic M2 acetylcholine receptors. By blocking acetylcholine released from postganglionic vagal nerve terminals, atropine abolishes parasympathetic inhibitory tone. This increases adenylyl cyclase activity, raises nodal cAMP, and accelerates SA node firing and AV node conduction velocity.
9Sodium-glucose cotransporter-2 (SGLT2) inhibitors, such as dapagliflozin and empagliflozin, are now guideline-directed medical therapy for heart failure with reduced ejection fraction (HFrEF). What key hemodynamic mechanism explains their cardiovascular benefit independent of glycemic control?
A.Potent direct arteriolar smooth muscle dilation via nitric oxide-cGMP pathway activation
B.Natriuresis and osmotic diuresis reducing cardiac preload, coupled with enhanced tubuloglomerular feedback and myocardial metabolic shift toward ketone utilization
C.Selective blockade of beta-adrenergic receptors preventing catecholamine-induced cardiomyocyte apoptosis
D.Direct inhibition of the cardiac sodium-calcium exchanger (NCX) restoring sarcoplasmic reticulum calcium load
Explanation: SGLT2 inhibitors block glucose and sodium reabsorption in the early proximal renal tubule. This promotes modest osmotic diuresis and natriuresis, decreasing interstitial fluid volume and reducing ventricular preload and afterload without sympathetic activation. Additionally, they restore tubuloglomerular feedback (reducing intraglomerular pressure), decrease systemic arterial stiffness, and shift myocardial fuel energetics from glucose to energetically efficient beta-hydroxybutyrate ketones.
10A patient receiving intravenous erythromycin for a severe atypical respiratory infection reports intense abdominal cramping and accelerated bowel movements. What pharmacological mechanism accounts for this gastrointestinal adverse reaction?
A.Direct competitive blockade of intestinal serotonin 5-HT3 receptors
B.Potent stimulation of peripheral gastrointestinal motilin receptors by the macrolide structure mimicking endogenous motilin
C.Profound inhibition of gastrointestinal acetylcholinesterase producing cholinergic hyperstimulation
D.Osmotic fluid drawing into the intestinal lumen due to poor mucosal absorption
Explanation: Macrolide antibiotics (particularly 14-membered rings like erythromycin and to a lesser extent clarithromycin) act as non-peptide agonists at gastrointestinal motilin receptors located on smooth muscle and enteric neurons. This triggers high-amplitude propagating contractions in the gastric antrum and duodenum (phase III migrating motor complexes), explaining the frequent side effects of nausea, abdominal cramps, and diarrhea (and erythromycin's off-label use as a prokinetic in gastroparesis).

About the Albania Pharmacist State Exam (Provimi i Shtetit - Farmaci) Exam

The Albanian Pharmacist State Exam (Provimi i Shtetit për Profesionin e Rregulluar të Farmacistit) is the mandatory statutory licensing examination in the Republic of Albania governed by Law No. 10171, dated 22.10.2009 'On Regulated Professions in the Republic of Albania' (as amended) and Law No. 105/2014 'On Drugs and Pharmaceutical Service'. Graduates holding an integrated Master of Science (MSc) in Pharmacy from accredited Albanian universities or recognized foreign institutions must pass this computer-based examination administered by the Center for Educational Services (QSHA) in Tirana following mandatory professional internship verification by the Order of Pharmacists of Albania (Urdhri i Farmacistëve të Shqipërisë - UFSH). Passing this examination is the final legal requirement for registration with UFSH and obtaining an unrestricted license to practice community pharmacy, hospital pharmacy, pharmaceutical manufacturing, wholesale distribution, or clinical research in Albania. QSHA's orientation programme for the pharmacist profession lists five disciplines without percentage weights: pharmacology, clinical pharmacology, medicinal chemistry and phytotherapy; pharmaceutical technology; chemical toxicology; biopharmaceutics and pharmacokinetics; and pharmaceutical legislation and management. Note: the official examination is administered in Albanian (Shqip); this practice question bank is an English-language multiple-choice study adaptation, not an official translation of the exam or a simulation of its format.

Assessment

One 60-minute computerised round at the QSHA examination centre in Tirana (Bulevardi Zhan D'Ark, Nr. 23). The system selects the items automatically and they are identical for every candidate in that session; marking is automatic and the result appears on screen at the end. Candidates report 30 minutes early with photo ID, mobile phones are prohibited, and a written appeal may be sent to QSHA within 10 days of the result.

Time Limit

60 minutes

Passing Score

At least 50% of the paper's total points (at least 50 of 100 points). Grades run from 4 (under 50 points) to 10 (95-100 points); grade 5 (50-54 points) is the minimum pass.

Exam Fee

10,000 ALL for the 1st attempt, 12,500 ALL (2nd), 15,000 ALL (3rd), 17,500 ALL (4th), 20,000 ALL (5th) and 25,000 ALL for the 6th or later attempt, under Council of Ministers Decision No. 560, dated 29.9.2018 on QSHA service tariffs. The fee is prepaid and non-refundable. (Qendra e Shërbimeve Arsimore (QSHA) & Urdhri i Farmacistëve të Shqipërisë (UFSH))

Albania Pharmacist State Exam (Provimi i Shtetit - Farmaci) Exam Content Outline

Not published

Pharmacology & Clinical Pharmacotherapeutics

Mechanisms of action, indications, pharmacodynamics, dosage regimens, adverse effects, and therapeutic monitoring across cardiovascular, antimicrobial, central nervous system, and endocrine medication classes.

Not published

Pharmaceutical Technology & Biopharmaceutics

Formulation design, solid and liquid dosage forms, sterile manufacturing, biopharmaceutics, bioavailability, dissolution kinetics, stability testing, and extemporaneous compounding principles.

Not published

Medicinal Chemistry & Toxicology

Chemical structures, structure-activity relationships (SAR), metabolic pathways, physicochemical properties, acute poisoning mechanisms, toxicokinetics, and specific antidotes.

Not published

Pharmacognosy & Phytotherapy

Plant-derived secondary metabolites (alkaloids, cardiac glycosides, flavonoids, tannins, essential oils), botanical origins, standardized extracts, phytotherapeutic applications, and herb-drug interactions.

Not published

Clinical Pharmacy, Drug Interactions & Patient Counseling

Pharmacokinetic and pharmacodynamic drug-drug interactions, contraindications in special populations (pregnancy, lactation, renal/hepatic impairment), therapeutic drug monitoring, and patient communication.

Not published

Pharmaceutical Legislation, Good Pharmacy Practice & Deontology

Albanian pharmaceutical legal framework (Law No. 10171, Law No. 105/2014), prescription dispensing rules, narcotics and psychotropic control, Good Pharmacy Practice (GPP), ethics, and UFSH deontology.

Not published

Biopharmaceutics & Pharmacokinetics

Listed as its own discipline (Biofarmacia dhe Farmakokinetika) in the QSHA orientation programme: pharmacokinetic models, intravenous and extravascular administration, constant-rate and multiple-dose regimens, absorption, distribution and excretion, bioavailability and bioequivalence.

How to Pass the Albania Pharmacist State Exam (Provimi i Shtetit - Farmaci) Exam

What You Need to Know

  • Passing score: At least 50% of the paper's total points (at least 50 of 100 points). Grades run from 4 (under 50 points) to 10 (95-100 points); grade 5 (50-54 points) is the minimum pass.
  • Assessment: One 60-minute computerised round at the QSHA examination centre in Tirana (Bulevardi Zhan D'Ark, Nr. 23). The system selects the items automatically and they are identical for every candidate in that session; marking is automatic and the result appears on screen at the end. Candidates report 30 minutes early with photo ID, mobile phones are prohibited, and a written appeal may be sent to QSHA within 10 days of the result.
  • Time limit: 60 minutes
  • Exam fee: 10,000 ALL for the 1st attempt, 12,500 ALL (2nd), 15,000 ALL (3rd), 17,500 ALL (4th), 20,000 ALL (5th) and 25,000 ALL for the 6th or later attempt, under Council of Ministers Decision No. 560, dated 29.9.2018 on QSHA service tariffs. The fee is prepaid and non-refundable.

Keys to Passing

  • Work through all 101 available questions
  • Review every answer and explanation
  • Track weak areas and revisit them
  • Use our AI tutor for tough concepts

Frequently Asked Questions

What is the passing score for the Albanian Pharmacist State Exam?

The exam is passed with at least 50% of the total points of the paper, that is at least 50 of 100 points. The published grading scale runs from 4 (under 50 points) through 5 (50-54), 6 (55-64), 7 (65-74), 8 (75-84), 9 (85-94) to 10 (95-100), so grade 5 is the minimum pass. The result appears on screen immediately and a written appeal may be sent to QSHA within 10 days of the result.

Where is the state exam administered?

The state exam is administered at the centralized electronic examination center of QSHA (Qendra e Shërbimeve Arsimore) located on Rruga 'Naim Frashëri', Nr. 37, Tirana, Albania. Testing is completed on individual secure computer terminals.

What legal acts govern the pharmacy profession and state exam in Albania?

The primary statutory acts are Law No. 10171, dated 22.10.2009 'On Regulated Professions in the Republic of Albania' (as amended) and Law No. 105/2014 'On Drugs and the Pharmaceutical Service' (as amended), along with relevant regulations issued by the Ministry of Health and Social Protection and UFSH.

How do I apply for the examination?

Applications are submitted online through the e-Albania portal ('Aplikim për provim shteti') during the official call announced by QSHA. Candidates must upload their verified degree, transcript, UFSH internship completion certificate, and proof of exam fee payment.

How much does the Albanian Pharmacist State Exam cost?

The fee for the first attempt is 10,000 ALL. Retake fees escalate by attempt: 12,500 ALL for the 2nd attempt, 15,000 ALL for the 3rd, 17,500 ALL for the 4th, and 20,000 ALL for the 5th and any subsequent attempts.

When and how do I receive my exam results?

Because the exam is computer-based, candidates receive their raw score and Pass/Fail result on their terminal screen immediately upon submitting the test. Official pass lists are subsequently published on the QSHA website (qsha.gov.al).

What happens after I pass the State Exam?

After passing, QSHA issues an official State Exam Certificate. Candidates present this certificate to the Order of Pharmacists of Albania (UFSH) to finalize their registration, take the professional oath, and obtain their permanent practicing license (Licenca e Ushtrimit të Profesionit).

Is there negative marking on the state exam?

No. There is no negative marking or point deduction for incorrect answers. Candidates receive 1 point for each correct answer and 0 points for unanswered or incorrect questions.

Can graduates of foreign pharmacy faculties sit for this exam?

Yes, provided their foreign pharmacy degree has undergone formal academic equivalence nostrification by the Ministry of Education and Sports in Albania and they have completed the required practical internship verified by UFSH.